Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections ; volume:19 ; number:1 ; day:19 ; month:6 ; year:2019 ; pages:1-16 ; date:12.2019
BMC health services research ; 19, Heft 1 (19.6.2019), 1-16, 12.2019
- Urheber
-
Debaveye, Sam
De Smedt, Delphine
Heirman, Bert
Kavanagh, Shane
Dewulf, Jo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-019-4247-2
- URN
-
urn:nbn:de:101:1-2019091114175091715575
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Debaveye, Sam
- De Smedt, Delphine
- Heirman, Bert
- Kavanagh, Shane
- Dewulf, Jo
- SpringerLink (Online service)
Ähnliche Objekte (12)
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The cost associated with administering risperidone long-acting injections in the Australian community
Health Status, Disability and Retirement Incentives in Belgium
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
The health-related social costs of alcohol in Belgium
Employment trajectories and mental health-related disability in Belgium
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study
Variations in Provision of Long-Acting Reversible Contraception Across Veterans Health Administration Facilities
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The cost associated with administering risperidone long-acting injections in the Australian community
Health Status, Disability and Retirement Incentives in Belgium
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
The health-related social costs of alcohol in Belgium
Employment trajectories and mental health-related disability in Belgium
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study
Variations in Provision of Long-Acting Reversible Contraception Across Veterans Health Administration Facilities
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The cost associated with administering risperidone long-acting injections in the Australian community
Health Status, Disability and Retirement Incentives in Belgium
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
The health-related social costs of alcohol in Belgium
Employment trajectories and mental health-related disability in Belgium
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study